Literature DB >> 17126961

Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium.

Michelle E Gahan1, Diane E Webster, Steven L Wesselingh, Richard A Strugnell.   

Abstract

Live attenuated Salmonellae may overcome limitations with conventional methods of DNA immunisation. This study examined the impact of plasmid stability on oral DNA delivery by the attenuated Salmonella enterica serovar Typhimurium vaccine strain BRD509. A DNA vaccine cassette comprising the C fragment of tetanus toxin under control of the cytomegalovirus (CMV) promoter was ligated into plasmid pcDNA3, pUC18, pBBR122, pACYC184, pRSF1010/CAT, pBR322 and pAT153. In vitro and in vivo stability studies revealed that, with the exception of pcDNA3 and pUC18, the plasmids were retained by BRD509. However, pAT153 was the only plasmid to induce a tetanus toxoid-specific antibody response following oral delivery. Plasmid copy number was found to impact on plasmid stability and the induction of antigen-specific humoral responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126961     DOI: 10.1016/j.vaccine.2006.10.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma.

Authors:  Zhipeng Liu; Xiufeng Liu; Wenmin Cao; Zi-Chun Hua
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.

Authors:  Jianxiang Chen; Dongping Wei; Hongqin Zhuang; Yiting Qiao; Bo Tang; Xiangyu Zhang; Jing Wei; Shentong Fang; Guo Chen; Pan Du; Xiaofeng Huang; Wenhui Jiang; Qingang Hu; Zi-Chun Hua
Journal:  Mol Cell Proteomics       Date:  2011-04-07       Impact factor: 5.911

3.  Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar Typhimurium.

Authors:  Jake N Matic; Tamsin D Terry; David Van Bockel; Tracy Maddocks; David Tinworth; Michael P Jennings; Steven P Djordjevic; Mark J Walker
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

Review 4.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

5.  Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.

Authors:  Xinxin Zhao; Qinlong Dai; Renyong Jia; Dekang Zhu; Mafeng Liu; Mingshu Wang; Shun Chen; Kunfeng Sun; Qiao Yang; Ying Wu; Anchun Cheng
Journal:  Front Cell Infect Microbiol       Date:  2017-09-04       Impact factor: 5.293

6.  Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.

Authors:  Yun-Wen Yang; Chun-Mei Zhang; Xian-Jie Huang; Xiao-Xin Zhang; Lin-Kai Zhang; Jia-Huang Li; Zi-Chun Hua
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

7.  Bacterial antigen expression is an important component in inducing an immune response to orally administered Salmonella-delivered DNA vaccines.

Authors:  Michelle E Gahan; Diane E Webster; Steven L Wesselingh; Richard A Strugnell; Ji Yang
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.